MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, GRTX has $7,196K in assets. $645K in debts. $6,375K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1100.00%
Quick Ratio
1100.00%
Cash Ratio
988.37%
Debt to Asset Ratio
8.96%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Other assets
    • Subscription receivable
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Series b redeemable convertible ...
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
6,375
Subscription receivable
0
Prepaid expenses and other current assets
720
Total current assets
7,095
Other assets
101
Total assets
7,196
Accounts payable
265
Accrued expenses
380
Total current liabilities
645
Royalty purchase liability
0
Warrant liability
0
Total liabilities
645
Series b redeemable convertible preferred stock, 0.001 par value 10,000,000 shares authorized 119,318 shares issued and outstanding at december 31, 2025 and 2024
2,577
Common stock, 0.001 par value 200,000,000 shares authorized 75,462,390 shares issued and outstanding at december 31, 2025 and 2024
75
Additional paid-in capital
311,213
Accumulated deficit
-307,314
Total stockholders' deficit
3,974
Total liabilities, redeemable convertible preferred stock and stockholders' deficit
7,196
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$6,375K Prepaid expenses andother current assets$720K Total current assets$7,095K Other assets$101K Total assets$7,196K Total liabilities,redeemable convertible...$7,196K Total stockholders'deficit$3,974K Series b redeemableconvertible preferred...$2,577K Total liabilities$645K Accumulated deficit-$307,314K Additional paid-in capital$311,213K Total currentliabilities$645K Common stock, 0.001 parvalue 200,000,000...$75K Accrued expenses$380K Accounts payable$265K

Galera Therapeutics, Inc. (GRTX)

Galera Therapeutics, Inc. (GRTX)